Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 4/2015

01.05.2015 | Originalien

The osteogenic potential of ligament fibroblasts is greater in ankylosing spondylitis patients than in patients with osteoarthritis

verfasst von: M. Yang, H. Yuan, M. Miao, W. Xu

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The goal of the present study was to investigate the osteogenic potential of ligament fibroblasts from patients with ankylosing spondylitis (AS).

Materials and methods

Ligament fibroblasts were isolated from tissues harvested from AS patients and patients with aseptic necrosis of the femoral head (ANFH) who had undergone total hip arthroplasty (THA). Cells were cultured in osteogenic induction medium (OIM) with or without bone morphogenetic protein 2 (BMP-2) for 30 days. During this time, the levels of alkaline phosphatase (ALP) and osteocalcin (OC) were determined as markers of osteogenesis.

Results

Ligament fibroblasts isolated from patients with AS exhibited significantly greater potential for differentiation than those isolated from patients with osteoarthritis (ANFH).

Conclusion

These findings illuminate osteogenesis as a new pathway for studying the mechanism underlying ankylosis in AS patients. Factors which cause localized stromal remodeling at the enthesis significantly influence formation of new bone and further research is required to determine the mechanisms responsible for the osteogenic potential of enthesis cells and ligament fibroblasts in AS patients.
Literatur
1.
Zurück zum Zitat Boulware D, Arnett F, Cush J et al (2003) The seronegative spondyloarthropathies. In: Koopman W, Boulware D, Heudebert G (eds) Clinical primer of rheumatology. Lippincott Williams & Wilkins, Philadelphia, p 127e63 Boulware D, Arnett F, Cush J et al (2003) The seronegative spondyloarthropathies. In: Koopman W, Boulware D, Heudebert G (eds) Clinical primer of rheumatology. Lippincott Williams & Wilkins, Philadelphia, p 127e63
2.
Zurück zum Zitat Machado P, Landewé R, Braun J et al (2010) Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis 69:1465–1470CrossRefPubMed Machado P, Landewé R, Braun J et al (2010) Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis 69:1465–1470CrossRefPubMed
3.
Zurück zum Zitat Chen J, Song D, Yuan W (2011) Is ossification of posterior longitudinal ligament an enthesopathy? Int Orthop (SICOT) 35:1511–1516 Chen J, Song D, Yuan W (2011) Is ossification of posterior longitudinal ligament an enthesopathy? Int Orthop (SICOT) 35:1511–1516
4.
Zurück zum Zitat Laatiris A, Amine B, Hajjaj-Hassouni N et al (2012) Enthesitis and its relationships with disease parameters in Moroccan patients with ankylosing spondylitis. Rheumatol Int 32(3):723–727CrossRefPubMed Laatiris A, Amine B, Hajjaj-Hassouni N et al (2012) Enthesitis and its relationships with disease parameters in Moroccan patients with ankylosing spondylitis. Rheumatol Int 32(3):723–727CrossRefPubMed
5.
Zurück zum Zitat Lories RJ, Matthys P, Derese I et al (2004) Ankylosing enthesitis, dactylitis and onychoperiostitis in a mouse model of psoriatic arthritis. Ann Rheum Dis 63:595–598CrossRefPubMedCentralPubMed Lories RJ, Matthys P, Derese I et al (2004) Ankylosing enthesitis, dactylitis and onychoperiostitis in a mouse model of psoriatic arthritis. Ann Rheum Dis 63:595–598CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Binks DA, Gravallese EM, Radjenovic A et al (2013) Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis. Ann Rheum Dis (Epub ahead of print) Binks DA, Gravallese EM, Radjenovic A et al (2013) Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis. Ann Rheum Dis (Epub ahead of print)
8.
Zurück zum Zitat Van der Linden S, Valkenburg H, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRef Van der Linden S, Valkenburg H, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRef
9.
Zurück zum Zitat Haynes KR, Pettit AR, Duan R et al (2012) Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors. Arthritis Res Ther 14(6):R253CrossRefPubMedCentralPubMed Haynes KR, Pettit AR, Duan R et al (2012) Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors. Arthritis Res Ther 14(6):R253CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Shu T, Chen GH, Rong L et al (2013) Indirect comparison of anti-TNF-α agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials. Clin Exp Rheumatol 31(5):717–722PubMed Shu T, Chen GH, Rong L et al (2013) Indirect comparison of anti-TNF-α agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials. Clin Exp Rheumatol 31(5):717–722PubMed
11.
Zurück zum Zitat Ducy P, Schinke T, Karsenty G (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289(5484):1501–1504CrossRefPubMed Ducy P, Schinke T, Karsenty G (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289(5484):1501–1504CrossRefPubMed
12.
Zurück zum Zitat Coelho MJ, Fernandes MH (2000) Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, betaglycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21(11):1095–1102CrossRefPubMed Coelho MJ, Fernandes MH (2000) Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, betaglycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21(11):1095–1102CrossRefPubMed
13.
Zurück zum Zitat Bandyopadhyay A, Yadav PS, Prashar P (2013) BMP signaling in development and diseases: a pharmacological perspective. Biochem Pharmacol 85(7):857–864CrossRefPubMed Bandyopadhyay A, Yadav PS, Prashar P (2013) BMP signaling in development and diseases: a pharmacological perspective. Biochem Pharmacol 85(7):857–864CrossRefPubMed
14.
Zurück zum Zitat Fromigue O, Modrowski D, Marie PJ (2005) Apoptosis in membranous bone formation: role of fibroblast growth factor and bone morphogenetic protein signaling. Crit Rev Eukaryot Gene Expr 15(1):75–92CrossRefPubMed Fromigue O, Modrowski D, Marie PJ (2005) Apoptosis in membranous bone formation: role of fibroblast growth factor and bone morphogenetic protein signaling. Crit Rev Eukaryot Gene Expr 15(1):75–92CrossRefPubMed
15.
Zurück zum Zitat Schett G (2012) Independent development of inflammation and new bone formation in ankylosing spondylitis. Arthritis Rheum. doi:10.1002/art.34441 Schett G (2012) Independent development of inflammation and new bone formation in ankylosing spondylitis. Arthritis Rheum. doi:10.1002/art.34441
16.
Zurück zum Zitat Spadaro A, Iagnocco A, Valesini G et al (2011) Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis. Rheumatology (Oxford) 50(11):2080–2086 Spadaro A, Iagnocco A, Valesini G et al (2011) Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis. Rheumatology (Oxford) 50(11):2080–2086
17.
Zurück zum Zitat Zhang J, Huang F, Zhang YM et al (2012) The efficacy of etanercept in enthesitis in ankylosing spondylitis and an evaluation method for enthesitis. Zhonghua Nei Ke Za Zhi 51(5):376–379PubMed Zhang J, Huang F, Zhang YM et al (2012) The efficacy of etanercept in enthesitis in ankylosing spondylitis and an evaluation method for enthesitis. Zhonghua Nei Ke Za Zhi 51(5):376–379PubMed
18.
Zurück zum Zitat Rudwaleit M, Claudepierre P, Kupper H et al (2010) Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis. Arthritis Res Ther 12(2):R43CrossRefPubMedCentralPubMed Rudwaleit M, Claudepierre P, Kupper H et al (2010) Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis. Arthritis Res Ther 12(2):R43CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Machado P (2013) Anti-tumor necrosis factor and new boneformation in ankylosing spondylitis: the controversy continues. Arthritis Rheum 65(10):2537–2540PubMed Machado P (2013) Anti-tumor necrosis factor and new boneformation in ankylosing spondylitis: the controversy continues. Arthritis Rheum 65(10):2537–2540PubMed
20.
Zurück zum Zitat Lories RJ, Derese I, De Bari C et al (2007) Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondyloarthritis. Arthritis Rheum 56:489–497CrossRefPubMed Lories RJ, Derese I, De Bari C et al (2007) Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondyloarthritis. Arthritis Rheum 56:489–497CrossRefPubMed
21.
Zurück zum Zitat Benjamin M, Toumi H, Suzuki D et al (2009) Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis 68:1003–1010CrossRefPubMed Benjamin M, Toumi H, Suzuki D et al (2009) Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis 68:1003–1010CrossRefPubMed
Metadaten
Titel
The osteogenic potential of ligament fibroblasts is greater in ankylosing spondylitis patients than in patients with osteoarthritis
verfasst von
M. Yang
H. Yuan
M. Miao
W. Xu
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe 4/2015
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-014-1394-z

Weitere Artikel der Ausgabe 4/2015

Zeitschrift für Rheumatologie 4/2015 Zur Ausgabe

Einführung zum Thema

Rheuma und Niere

Mitteilungen der DGRh

Mitteilungen

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.